ALMKT:EPA
Mauna Kea Technologies SA
0,13 €
arrow_upward
+1,10%(+0,0014) 1 d
7 okt., 17:13:21 GMT+2 · EUR
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för ALMKT …
Öppen
0,13 €
Högt
0,13 €
Lågt
0,13 €
Börsvärde
23,13 mn
Genomsn. vol.
503,79 tn
Volym
424,31 tn
P/E-tal
1,05
52v högst
0,23 €
52v lägst
0,07 €
EPS
0,12 €
Utestående aktier
195,26 mn
Antal anställda
59
Öppen
0,13 €
Högt
0,13 €
Lågt
0,13 €
Börsvärde
23,13 mn
Genomsn. vol.
503,79 tn
Volym
424,31 tn
P/E-tal
1,05
52v högst
0,23 €
52v lägst
0,07 €
EPS
0,12 €
Utestående aktier
195,26 mn
Antal anställda
59
Nyheter och artiklar
Från webbkällor och nyhetspartner
TipRanks
·
för 22 timmar sedan
Mauna Kea Discloses Updated Share Capital and Voting Rights Structure
Yahoo! Finance Canada
·
för 23 timmar sedan
Mauna Kea Technologies : Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Om Mauna Kea Technologies SA